Trial Details
TERMINATEDBasic Information
| Clinical ID | c1305 |
|---|---|
| Identifier | NCT03169894 |
| Trial Title | Evaluation of the Safety, Tolerability, and Efficacy of MDGN-002 in Adults With Moderate to Severe Active Crohn's Disease or Ulcerative Colitis |
| Trial URL | Visit Original Page |
Study Information
| Study Results | YES |
|---|---|
| Conditions | Crohn Disease|Ulcerative Colitis |
| Interventions | DRUG: MDGN-002 |
Participant Information
| Sponsor | Avalo Therapeutics, Inc. |
|---|---|
| City | Hialeah |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1 |
Time Information
| Start Date | 2017-07-14 |
|---|---|
| Primary Completion Date | 2021-09-14 |
| Completion Date | 2021-10-12 |